The Centre for Health Protection today said it is investigating 3,172 additional locally acquired COVID-19 cases, of which 449 were identified through nucleic acid tests and 2,723 via rapid antigen tests. Separately, 111 imported cases were detected. Furthermore, seven residential care homes for the elderly and five for disabled people logged 13 cases involving their residents. The Hospital Authority reported that 20 patients passed away in public hospitals. According to a preliminary analysis, the cause of death for nine patients was related to COVID-19, while that of the remaining 11 patients was unrelated. It also registered eight more critical cases, bringing the number of patients in critical condition to 93. Separately, to align with the Government’s cancellation of issuing isolation orders from tomorrow, the authority will, starting from the same day, announce at 8.30am and 1pm the information of general out-patient clinics (GOPC) quota reserved for COVID-19
The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation assessed three death cases with history of vaccination during its meeting today.
As of April 4, the Department of Health received a total of 15 death reports with history of COVID-19 immunisation from the Hospital Authority.
The cases involve 11 men and four women aged between 55 and 80. Existing information indicates that most of these cases died of cardiovascular diseases.
Three of the cases were assessed in today's meeting.
The first case involves a 67-year-old man who passed away on March 13. The full autopsy report indicated that the patient died of acute myocardial infarction due to coronary atherosclerosis, while other investigations did not reveal possible immunological reactions due to a vaccine.
The committee considered that there was no causal relationship between the deceased's outcome and COVID-19 vaccination.
The second case involves a 68-year-old woman with hypertension, hypothyroidism and lipid disorder who passed away on March 29 and received a dose of CoronaVac 26 days before her death.
Based on the preliminary autopsy findings of acute myocardial infarction, the committee considered that the deceased's outcome was not directly associated with COVID-19 vaccination.
The last case involves a 62-year-old man with a history of newly diagnosed hypertension who passed away on April 2 and received a dose of CoronaVac 25 days prior to his death. The causality assessment will be conducted when preliminary autopsy findings are available.
http://dlvr.it/RxBS5R
http://dlvr.it/RxBS5R